White matter alterations in Alzheimer’s disease without concomitant pathologies

Most individuals with AD neuropathological changes have co‐morbidities which have an impact on the integrity of the WM. This study analyses oligodendrocyte and myelin markers in the frontal WM in a series of AD cases without clinical or pathological co‐morbidities.

• Publication year

  2020

• Venue

  Neuropathology and Applied Neurobiology

• Publication date

  2020-04-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/nan.12618PMID 32255227PMCID 7754505
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• White matter alterations in Alzheimer’s disease without concomitant pathologies

  2020cited by this paper
• Oligodendroglial Cells in Alzheimer's Disease.

  2019cited by this paper
• Brain‐derived and circulating vesicle profiles indicate neurovascular unit dysfunction in early Alzheimer’s disease

  2019cited by this paper
• Aβ oligomers promote oligodendrocyte differentiation and maturation via integrin β1 and Fyn kinase signaling

  2019cited by this paper
• White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson's disease with dementia, and Alzheimer's disease.

  2018cited by this paper
• Oligodendrogliopathy in neurodegenerative diseases with abnormal protein aggregates: The forgotten partner.

  2018cited by this paper
• Multimorbidity Is Associated with Preclinical Alzheimer’s Disease Neuroimaging Biomarkers

  2018cited by this paper
• Evidence of demyelination in mild cognitive impairment and dementia using a direct and specific magnetic resonance imaging measure of myelin content

  2018cited by this paper
• An emerging role of dysfunctional axon-oligodendrocyte coupling in neurodegenerative diseases

  2018cited by this paper
• Medical Comorbidity in Alzheimer’s Disease: A Nested Case-Control Study

  2018cited by this paper
• Myelin changes at the early stage of 5XFAD mice.

  2018cited by this paper
• Myelin content changes in probable Alzheimer's disease and mild cognitive impairment: Associations with age and severity of neuropsychiatric impairment

  2018cited by this paper
• Association between Alzheimer’s disease pathogenesis and early demyelination and oligodendrocyte dysfunction

  2018cited by this paper
• Review: Vascular dementia: clinicopathologic and genetic considerations

  2018cited by this paper
• White matter changes in Alzheimer’s disease: a focus on myelin and oligodendrocytes

  2018cited by this paper
• Comorbidity Analysis between Alzheimer’s Disease and Type 2 Diabetes Mellitus (T2DM) Based on Shared Pathways and the Role of T2DM Drugs

  2017cited by this paper
• DNA damage in the oligodendrocyte lineage and its role in brain aging.

  2017cited by this paper
• Parietal white matter lesions in Alzheimer’s disease are associated with cortical neurodegenerative pathology, but not with small vessel disease

  2017cited by this paper
• The blood-brain barrier in Alzheimer's disease

  2017cited by this paper
• Axonal and myelinic pathology in 5xFAD Alzheimer’s mouse spinal cord

  2017cited by this paper
• Aging of cerebral white matter.

  2017cited by this paper
• Microstructural white matter alterations in preclinical Alzheimer’s disease detected using free water elimination diffusion tensor imaging

  2017cited by this paper
• Diversity of astroglial responses across human neurodegenerative disorders and brain aging

  2017cited by this paper
• Comorbidity and progression of late onset Alzheimer’s disease: A systematic review

  2017cited by this paper
• Associations between amyloid β and white matter hyperintensities: A systematic review

  2017cited by this paper
• Neuropathology of cerebrovascular diseases.

  2017cited by this paper
• Update on Vascular Dementia

  2016cited by this paper
• Decreased Regenerative Capacity of Oligodendrocyte Progenitor Cells (NG2-Glia) in the Ageing Brain: A Vicious Cycle of Synaptic Dysfunction, Myelin Loss and Neuronal Disruption?

  2016cited by this paper
• Oligodendrocytes and Alzheimer's disease

  2016cited by this paper
• Post-mortem assessment in vascular dementia: advances and aspirations

  2016cited by this paper
• Loss of ceramide synthase 2 activity, necessary for myelin biosynthesis, precedes tau pathology in the cortical pathogenesis of Alzheimer's disease.

  2016cited by this paper
• Neuropathologic comorbidity and cognitive impairment in the Nun and Honolulu-Asia Aging Studies

  2016cited by this paper
• Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer’s disease

  2016cited by this paper
• Contribution of the oligodendrocyte lineage to CNS repair and neurodegenerative pathologies.

  2016cited by this paper
• White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network

  2016cited by this paper
• Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment.

  2016cited by this paper
• Age‐Associated White Matter Lesions: The MRC Cognitive Function and Ageing Study

  2015cited by this paper
• MAG, myelin and overcoming growth inhibition in the CNS

  2015cited by this paper
• PART is part of Alzheimer disease

  2015cited by this paper
• Insights into White Matter Damage in Alzheimer's Disease: From Postmortem to in vivo Diffusion Tensor MRI Studies

  2015cited by this paper
• Soluble amyloid beta levels are elevated in the white matter of Alzheimer’s patients, independent of cortical plaque severity

  2014cited by this paper
• Age-related decline in white matter integrity in a mouse model of tauopathy: an in vivo diffusion tensor magnetic resonance imaging study.

  2014cited by this paper
• Oxidative Glial Cell Damage Associated with White Matter Lesions in the Aging Human Brain

  2014cited by this paper
• Primary age-related tauopathy (PART): a common pathology associated with human aging

  2014cited by this paper
• Disconnected aging: cerebral white matter integrity and age-related differences in cognition.

  2014cited by this paper
• Blood-Brain Barrier Dysfunction and Cerebral Small Vessel Disease (Arteriolosclerosis) in Brains of Older People

  2014cited by this paper
• The myelin membrane-associated enzyme 2′,3′-cyclic nucleotide 3′-phosphodiesterase: on a highway to structure and function

  2014cited by this paper
• Comorbidity in Dementia: Update of an Ongoing Autopsy Study

  2014cited by this paper
• White matter changes in preclinical Alzheimer's disease: a magnetic resonance imaging-diffusion tensor imaging study on cognitively normal older people with positive amyloid β protein 42 levels.

  2014cited by this paper
• Contemplating Alzheimer’s Disease and the Contribution of White Matter Hyperintensities

  2013cited by this paper
• Blood–Brain Barrier Dysfunction as a Cause and Consequence of Alzheimer's Disease

  2013cited by this paper
• White matter tract integrity metrics reflect the vulnerability of late-myelinating tracts in Alzheimer's disease☆

  2013cited by this paper
• Dynamic changes in myelin aberrations and oligodendrocyte generation in chronic amyloidosis in mice and men

  2013cited by this paper
• Neuropathologic basis of white matter hyperintensity accumulation with advanced age

  2013cited by this paper
• MYRF Is a Membrane-Associated Transcription Factor That Autoproteolytically Cleaves to Directly Activate Myelin Genes

  2013cited by this paper
• The role of myelin and oligodendrocytes in axonal energy metabolism.

  2013cited by this paper
• White matter abnormalities associated with Alzheimer’s disease and mild cognitive impairment: a critical review of MRI studies

  2013cited by this paper
• NG2 cells, a new trail for Alzheimer’s disease mechanisms?

  2013cited by this paper
• Defining Alzheimer as a common age-related neurodegenerative process not inevitably leading to dementia.

  2012cited by this paper
• Myelin Gene Regulatory Factor Is Required for Maintenance of Myelin and Mature Oligodendrocyte Identity in the Adult CNS

  2012cited by this paper
• Vascular dementia: different forms of vessel disorders contribute to the development of dementia in the elderly brain.

  2012cited by this paper
• Oligodendroglia metabolically support axons and contribute to neurodegeneration

  2012cited by this paper
• Differential cell proliferation in the cortex of the appsweps1de9 alzheimer's disease mouse model

  2012cited by this paper
• Decreased Oligodendrocyte Nuclear Diameter in Alzheimer's Disease and Lewy Body Dementia

  2012cited by this paper
• Regional and cell-type specific distribution of HDAC2 in the adult mouse brain

  2012cited by this paper
• White matter imaging changes in subjective and mild cognitive impairment

  2012cited by this paper
• Age-related changes in human and non-human primate white matter: from myelination disturbances to cognitive decline

  2011cited by this paper
• Regulation of Oligodendrocyte Development and Myelination by Glucose and Lactate

  2011cited by this paper
• White matter hyperintensities and changes in white matter integrity in patients with Alzheimer’s disease

  2011cited by this paper
• Possible Retrogenesis Observed with Fiber Tracking: An Anteroposterior Pattern of White Matter Disintegrity in Normal Aging and Alzheimer's Disease

  2011cited by this paper
• Alzheimer's disease.

  2011cited by this paper
• Review: Cerebral microvascular pathology in ageing and neurodegeneration

  2011cited by this paper
• The Blood-Brain Barrier and Microvascular Water Exchange in Alzheimer's Disease

  2011cited by this paper
• Mass and relative elution time profiling: two-dimensional analysis of sphingolipids in Alzheimer's disease brains.

  2011cited by this paper
• Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years

  2011cited by this paper
• Emerging functions of myelin‐associated proteins during development, neuronal plasticity, and neurodegeneration

  2011cited by this paper
• Alzheimer's disease as homeostatic responses to age-related myelin breakdown.

  2011cited by this paper
• Early oligodendrocyte/myelin pathology in Alzheimer's disease mice constitutes a novel therapeutic target.

  2010cited by this paper
• Cognitive impairment of vascular origin: neuropathology of cognitive impairment of vascular origin.

  2010cited by this paper
• Vascular pathology in the aged human brain

  2010cited by this paper
• CNS-resident glial progenitor/stem cells produce Schwann cells as well as oligodendrocytes during repair of CNS demyelination.

  2010cited by this paper
• Amyloid Deposition and Influx Transporter Expression at the Blood-Brain Barrier Increase in Normal Aging

  2010cited by this paper
• Quantification of myelin loss in frontal lobe white matter in vascular dementia, Alzheimer’s disease, and dementia with Lewy bodies

  2010cited by this paper
• NG2 Glia Generate New Oligodendrocytes But Few Astrocytes in a Murine Experimental Autoimmune Encephalomyelitis Model of Demyelinating Disease

  2010cited by this paper
• Amyloid Efflux Transporter Expression at the Blood-Brain Barrier Declines in Normal Aging

  2010cited by this paper
• Regional white matter volume differences in nondemented aging and Alzheimer's disease

  2009cited by this paper
• Myelin Proteomics: Molecular Anatomy of an Insulating Sheath

  2009cited by this paper
• HDAC1 and HDAC2 Regulate Oligodendrocyte Differentiation By Disrupting β-Catenin-TCF Interaction

  2009cited by this paper
• Triple‐transgenic Alzheimer's disease mice exhibit region‐specific abnormalities in brain myelination patterns prior to appearance of amyloid and tau pathology

  2009cited by this paper
• Myelin gene regulatory factor is a critical transcriptional regulator required for CNS myelination.

  2009cited by this paper
• Cerebral amyloid angiopathy and its relationship to Alzheimer’s disease

  2008cited by this paper
• Heterogeneity of White Matter Hyperintensities in Alzheimer's Disease: Post-Mortem Quantitative MRI and Neuropathology

  2008cited by this paper
• A Transcriptome Database for Astrocytes, Neurons, and Oligodendrocytes: A New Resource for Understanding Brain Development and Function

  2008cited by this paper
• Spatial Distribution of White-Matter Hyperintensities in Alzheimer Disease, Cerebral Amyloid Angiopathy, and Healthy Aging

  2008cited by this paper
• Induction of oligodendrocyte differentiation by Olig2 and Sox10: evidence for reciprocal interactions and dosage-dependent mechanisms.

  2007cited by this paper
• The enigma of vascular cognitive disorder and vascular dementia

  2007cited by this paper
• The enigma of mixed dementia

  2007cited by this paper
• Aquaporin expression in the cerebral cortex is increased at early stages of Alzheimer disease.

  2007cited by this paper
• Presenilin-1 mutation sensitizes oligodendrocytes to glutamate and amyloid toxicities, and exacerbates white matter damage and memory impairment in mice

  2007cited by this paper
• Cognitive impact of subcortical vascular and Alzheimer's disease pathology

  2006cited by this paper

• Microglia-derived APOE2 improves remyelination even in the presence of endogenous APOE4

  2025cites this paper
• Early axonal degeneration linked to clinical decline in Alzheimer’s disease progression revealed with diffusion MRI

  2025cites this paper
• White Matter N-Acylphosphatidylserines (NAPSs) and Myelin Dysfunction in Late-Onset Alzheimer’s Disease (LOAD): A Pilot Study

  2025cites this paper
• The effect of Alzheimer's disease genetic factors on limbic white matter microstructure

  2025cites this paper
• Neuron-Glial2 (NG2) Cells: A Promising Target for Neuroinflammation-Related Neurodegeneration

  2025cites this paper
• Astrocyte and oligodendrocyte pathology in Alzheimer's disease

  2025cites this paper
• PKC-dependent MYRF dysregulation links Aβ pathology to oligodendrocyte, myelin and cognitive alterations in Alzheimer’s disease

  2025cites this paper
• Axonal Degeneration Across the Alzheimer’s Disease Spectrum: A Longitudinal MRI and Fluid Biomarker Study

  2025cites this paper
• Dysregulated synaptic gene expression in oligodendrocytes of spinal and bulbar muscular atrophy

  2025cites this paper
• Are Oligodendrocytes the Culprits or Victims in Alzheimer’s Disease

  2025cites this paper
• [18F]Florbetapir Pet Uptake Differences in White Matter Across the Alzheimer's Disease Continuum: From Cognitively Normal to MCI and Dementia

  2025cites this paper
• Exploring non-canonical targets in Alzheimer’s disease: a departure from the norm

  2024cites this paper
• Cerebral white matter rarefaction has both neurodegenerative and vascular causes and may primarily be a distal axonopathy.

  2023cites this paper
• White matter injury, cholesterol dysmetabolism, and APP/Abeta dysmetabolism interact to produce Alzheimer’s disease (AD) neuropathology: A hypothesis and review

  2023cites this paper
• Myelin in Alzheimer’s disease: culprit or bystander?

  2023cites this paper
• The Effects and Mechanism of Scutellaria baicalensis Georgi Stems and Leaves Flavonoids on Myelin Sheath Degeneration Induced by Composited Aβ in Rats.

  2023cites this paper
• Lipidomic Alterations in the Cerebral Cortex and White Matter in Sporadic Alzheimer’s Disease

  2022cites this paper
• Proteomic Mapping of the Human Myelin Proteome.

  2022cites this paper
• Bioinformatics Analysis of Publicly Available Single-Nuclei Transcriptomics Alzheimer’s Disease Datasets Reveals APOE Genotype-Specific Changes Across Cell Types in Two Brain Regions

  2022cites this paper
• White matter hyperintensities are a prominent feature of autosomal dominant Alzheimer’s disease that emerge prior to dementia

  2022cites this paper
• Dietary Selenomethionine Reduce Mercury Tissue Levels and Modulate Methylmercury Induced Proteomic and Transcriptomic Alterations in Hippocampi of Adolescent BALB/c Mice

  2022cites this paper
• Alzheimer's disease is an inherent, natural part of human brain aging: an integrated perspective.

  2022cites this paper
• 18F- orbetapir PET as a marker of myelin integrity across the Alzheimer’s disease spectrum

  2021cites this paper
• The emerging role of the chondroitin sulfate proteoglycan family in neurodegenerative diseases

  2021cites this paper
• Retinoid X Receptor activation promotes re-myelination in a very old triple transgenic mouse model of Alzheimer's disease.

  2021cites this paper
• Contribution of astrocytes to neuropathology of neurodegenerative diseases.

  2021cites this paper
• Recent update on the heterogeneity of the Alzheimer’s disease spectrum

  2021cites this paper
• Plasma exchange with albumin replacement and disease progression in amyotrophic lateral sclerosis: a pilot study

  2021cites this paper
• Dysregulated protein phosphorylation as main contributor of granulovacuolar degeneration at the first stages of NFT pathology.

  2021cites this paper
• Disturbance of phylogenetic layer-specific adaptation of human brain gene expression in Alzheimer's disease

  2021cites this paper
• Clemastine Ameliorates Perioperative Neurocognitive Disorder in Aged Mice Caused by Anesthesia and Surgery

  2021cites this paper
• 18F-florbetapir PET as a marker of myelin integrity across the Alzheimer’s disease spectrum

  2021cites this paper
• Dysregulated protein phosphorylation: A determining condition in the continuum of brain aging and Alzheimer's disease

  2021cites this paper
• Single-cell transcriptomic analysis elucidates APOE genotype specific changes across cell types in two brain regions in Alzheimer’s disease

  2021cites this paper
• Dietary Protein Source Influences Brain Inflammation and Memory in a Male Senescence-Accelerated Mouse Model of Dementia

  2020cites this paper
• White matter alterations in Alzheimer’s disease without concomitant pathologies

  2020cites this paper
• A Novel Logistic Model for Predicting Risk Factors and Contribution of Cerebral Small Vessel Disease

  year unknowncites this paper